China Pharma Holdings (CPHI) Finished Goods (2017 - 2024)
China Pharma Holdings' (CPHI) quarterly Finished Goods came in at $1.3 million in Q3 2024, up 6.83% YoY from $1.2 million in Q4 2023, and down 15.8% on a QoQ basis from $1.5 million in Q2 2024.
China Pharma Holdings (CPHI) Finished Goods (2017 - 2024) Analysis & Trends
China Pharma Holdings (CPHI) has 8 years of Finished Goods data on file, last reported at $1.3 million in Q3 2024.
- Quarterly Finished Goods rose 6.83% year-over-year to $1.3 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.3 million (up 6.83% YoY) and the FY2023 annual result came in at $1.5 million, up 166.73% from the prior year.
- Finished Goods declined to $1.3 million in Q3 2024, from $1.5 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $1.7 million in Q1 2024 to a low of $551000.0 in Q4 2021.
- A 5-year average of $1.2 million and a median of $1.3 million in 2022 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2021 — Finished Goods slumped 46.0% — and 2023, when it soared 166.73%.
- Tracing CPHI's Finished Goods over 5 years: stood at $960375.0 in 2020, then slumped by 42.63% to $551000.0 in 2021, then changed by 0.0% to $551000.0 in 2022, then jumped by 166.73% to $1.5 million in 2023, then slipped by 11.91% to $1.3 million in 2024.
- The last three Finished Goods figures came in at $1.3 million (Q3 2024), $1.5 million (Q2 2024), and $1.7 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China Pharma Holdings | 42.35 Mn | 42.04 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 551,000.00 |
| Sep 30, 2022 | 713,263.00 |
| Jun 30, 2022 | 1.28 Mn |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 795,524.00 |
| Jun 30, 2021 | 761,657.00 |
| Mar 31, 2021 | 1.53 Mn |
| Dec 31, 2020 | 960,375.00 |
| Sep 30, 2020 | 1.02 Mn |
| Jun 30, 2020 | 1.41 Mn |
| Mar 31, 2020 | 1.45 Mn |
| Dec 31, 2019 | 1.16 Mn |
| Sep 30, 2019 | 1.31 Mn |